MLTX — MOONLAKE IMMUNOTHERAPEUTICS

Ownership history in Squarepoint Ops LLC  ·  13 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q2)
Avg. % of fund
0.0%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 121,640 +108,740 +842.9% 0.00% $1.6M $13.18
2025 Q3 REDUCED 12,900 -17,790 -58.0% 0.00% $92K $7.17
2025 Q3 ADDED 30,690 +13,119 +74.7% 0.00% $220K $7.17
2025 Q2 ADDED 17,571 +629 +3.7% 0.00% $829K $47.20
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MLTX price (monthly, adj. close)

Other funds also holding MLTX

As of 2025 Q4 — sorted by position size

BVF INC/IL 3Y 7Y 8.76% Lion Point Capital, LP 3Y 7Y 4.6% Cormorant Asset Management, LP 3Y 7Y 2.65% Logos Global Management LP 3Y 1.39% Deep Track Capital, LP 3Y 1.08% Vivo Capital, LLC 3Y 7Y 0.85% STEMPOINT CAPITAL LP 0.79% Eagle Health Investments LP 3Y 0.54% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Rhenman & Partners Asset Management AB 3Y 7Y 0.45%
← Back to Squarepoint Ops LLC Holdings